INFECTIOUS AND INFLAMMATORY COMPLICATIONS IN OPHTHALMOLOGY AMID COVID-19

Authors

  • Kamilov Khalidjan Mahamadjanovich
  • Kasimova Munirakhon Sadikzhanovna
  • Khamraeva Gavkhar Khusanovna
  • Rizaeva Manzurakhon Asrorovna

Keywords:

Ophthalmology, COVID-19, complications, ulcers, endoophthalmitis, panophthalmitis, gastrointestinal tract, cavernous sinus thrombosis

Abstract

 Inflammatory complications of the organ of vision in the time of COVID-19 can be manifested as conjunctivitis, scleritis, episcleritis, keratitis, uveitis and optic neuritis. It is essential to collect anamnesis, examine the blood for the presence of COVID 19 and treat these patients with the help of infectious disease specialists. Correct diagnosis of inflammatory ocular complications in the presence of COVID 19 makes it possible to prevent ocular complications, such as: ulcers and corneal penetration; fusion and overgrowth of the pupil, which lead to secondary glaucoma; endoophthalmitis, panophthalmitis and optic nerve atrophy. Timely intensive medical care and adequate treatment of these complications lead to a decrease in disability in this category of patients.

References

Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., Zhou H., Hu Z., Zhou W., Zhao L., Chen J., Meng Y., Wang J., Lin Y., Yuan J., Xie Z., Ma J., Liu WJ., Wang D., Xu W., Holmes EC., Gao GF., Wu G., Chen W., Shi W., Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020 Feb 22; 395(10224):565–574. DOI: 10.1016/S0140‑ 6736(20)30251‑8

To K.F., Lo A.W. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‑CoV) and its putative receptor, angiotensin‑converting enzyme 2 (ACE2). The Journal of pathology. 2004 Jul;203(3):740–743. DOI: 10.1002/path.1597

Guo Y.R., Cao Q.D., Hong Z.S., Tan Y.Y., Chen S.D., Jin H.J., Tan K.S., Wang D.Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID‑19) outbreak an update on the status. Military Medical Research 2020;7(1):1. DOI: 10.1186/s40779‑020‑00240‑0

Tu H., Tu S., Gao S., Shao A., Sheng J. Current epidemiological and clinical fea‑ tures of COVID‑19; a global perspective from China. The Journal of infection. 2020;81(1):1–9. DOI: 10.1016/j.jinf.2020.04.011

Peiris J.S., Yuen K.E., Osterhaus A., Stöhr K. The severe acute respiratory syndrome. The New England journal of medicine. 2003 Dec 18;349(25):2431–2441. DOI: 10.1056/NEJMra032498

Xia J., Tong J., Liu M., Shen Y., Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‑CoV‑2 infection. Journal of medical virology. 2020 Jun;92(6):589–594. DOI: 10.1002/jmv.25725

Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zim‑ mer T., Thiel V., Janke C., Guggemos W., Seilmaier M., Drosten C., Vollmar P., Zwir‑ glmaier K., Zange S., Wölfel R., Hoelscher M. Transmission of 2019‑nCoV Infection from an Asymptomatic Contact in Germany. The New England journal of medicine. 2020;382(10):970–971. DOI: 10.1056/ NEJMc2001468.30

Zou L., Ruan F., Huang M., Liang L., Huang H., Hong Z., Yu J., Kang M., Song Y., Xia J., Guo Q., Song T., He J., Yen H.L., Peiris M., Wu J. SARS‑Cov‑2 Viral Load in Upper Respiratory Specimens of Infected Patients. The New England journal of medicine. 2020 :382(12):1177–1179. DOI: 10.1056/NEJMc2001737

Smirnov V.S., Totolyan A.A. Innate immunity in coronavirus infection. Russian Journal of Infection and Immunity = Infekciya i immunitet 2020;10(2):259–268 (In Russ.). DOI: 10.15789/2220‑7619‑III‑1440

Wölfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Müller M.A., Nie‑ meyer D., Jones T.C., Vollmar P., Rothe C., Hoelscher M., Bleicker T., Brünink S., Schneider J., Ehmann R., Zwirglmaier K., Drosten C., Wendtner C. Virological as‑ sessment of hospitalized patients with COVID‑2019. Nature. 2020;581(7809):465– 469. DOI: 10.1038/s41586‑020‑2196‑x

Javorac D., Grahovac L., Manić L., Stojilković N., Anđelković M., Bulat Z., Đukić‑ Ćosić D., Curcic M., Djordjevic A.B. An overview of the safety assessment of medicines currently used in the COVID‑19 disease treatment. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2020 Oct;144:111639. DOI: 10.1016/j.fct.2020.111639

Feautures of Diseases of the Anterior part of the EYE in Patients after COVID-19. Russion journal of Ophthalmology 2021.

SARS-CoV-2 Isolations From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection /F.Colavita D.Lapa , F.Carletti[et.al]// Ann Intern Med.-2020.Vol.173,№3-P.242-243.

Clinical case of corneal ulcer after COVID-19 viral infection. Ustinova I.V., Klimova E.S., Sakharova S.V., Novikova N.V. Youth Science Week-2021. Tyumen.

Kasimova M.S., Khamraeva G.H., Umarov R.Z. Diagnostics of Patients With Thromboembolic Complications Of The Visual Organ of Rhinosinusogenic Etiology At Covid 19. UZBEK MEDICAL JOURNAL 2020

Korelina V.E., Gazizova I.R., Kuroedov A.V., Didur M.D. The novel coronavirus infection (COVID-19) provides powerful effects on all pathogenic aspects of the primary open-angle glaucoma. Russion Medical Journal 2021.

Downloads

Published

2021-10-25